scholarly article | Q13442814 |
P356 | DOI | 10.1111/JTH.12557 |
P8608 | Fatcat ID | release_twdmqtjfajajjpeesdq565uk5a |
P932 | PMC publication ID | 4055511 |
P698 | PubMed publication ID | 24628740 |
P5875 | ResearchGate publication ID | 260802035 |
P50 | author | Bruce M. Psaty | Q30429993 |
Jerome I Rotter | Q59813011 | ||
Roger S. Blumenthal | Q106623018 | ||
P2093 | author name string | D S Siscovick | |
N S Jenny | |||
R A Kronmal | |||
P2860 | cites work | Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease | Q28139544 |
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Q29614697 | ||
Multi-Ethnic Study of Atherosclerosis: objectives and design | Q29615490 | ||
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies | Q29615686 | ||
Associations of inflammatory markers with coronary artery calcification: results from the Multi-Ethnic Study of Atherosclerosis | Q33695638 | ||
PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation | Q34106947 | ||
CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma | Q34114924 | ||
Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation | Q34128052 | ||
Production of the long pentraxin PTX3 in advanced atherosclerotic plaques | Q34128059 | ||
Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies | Q34154838 | ||
Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response | Q34159058 | ||
Evaluating the incremental value of new biomarkers with integrated discrimination improvement | Q35450631 | ||
Calcified coronary artery plaque measurement with cardiac CT in population-based studies: standardized protocol of Multi-Ethnic Study of Atherosclerosis (MESA) and Coronary Artery Risk Development in Young Adults (CARDIA) study. | Q35993254 | ||
Measuring coronary calcium on CT images adjusted for attenuation differences | Q36109472 | ||
The long pentraxin PTX3 in vascular pathology | Q36615475 | ||
Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | Q37141153 | ||
Net reclassification indices for evaluating risk prediction instruments: a critical review | Q37569098 | ||
Plasma PTX3 protein levels inversely correlate with insulin secretion and obesity, whereas visceral adipose tissue PTX3 gene expression is increased in obesity | Q39477901 | ||
Expression of long pentraxin PTX3 in human adipose tissue and its relation with cardiovascular risk factors. | Q46525885 | ||
The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation | Q47265306 | ||
Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. | Q51040637 | ||
Useful tests of usefulness of new risk factors: tools for assessing reclassification and discrimination. | Q51609401 | ||
Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. | Q53476226 | ||
Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. | Q53502969 | ||
Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis | Q56942567 | ||
Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris | Q56942761 | ||
Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey | Q57417409 | ||
Laboratory methods and quality assurance in the Cardiovascular Health Study | Q72588345 | ||
Elevated concentrations of pentraxin 3 are associated with coronary plaque vulnerability | Q84370651 | ||
Different distribution of pentraxin 3 and C-reactive protein in coronary atherosclerotic plaques | Q84564232 | ||
P433 | issue | 6 | |
P921 | main subject | circulatory system | Q11068 |
atherosclerosis | Q12252367 | ||
cardiovascular disease | Q389735 | ||
multiethnicity | Q111242702 | ||
P304 | page(s) | 999-1005 | |
P577 | publication date | 2014-06-01 | |
P1433 | published in | Journal of Thrombosis and Haemostasis | Q6296004 |
P1476 | title | Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis | |
P478 | volume | 12 |
Q93186355 | Administration of Intravenous Iron Formulations Induces Complement Activation in-vivo |
Q49833796 | An exploratory factor analysis of inflammatory and coagulation markers associated with femoral artery atherosclerosis in the San Diego Population Study |
Q55001432 | Association of pentraxin and high-sensitive C-reactive protein as inflammatory biomarkers in patients with chronic periodontitis and peripheral arterial disease. |
Q38812151 | Association of peripheral arterial disease with periodontal disease: analysis of inflammatory cytokines and an acute phase protein in gingival crevicular fluid and serum |
Q47813656 | C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques |
Q89834282 | Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction |
Q92876531 | Immune-Mediated Inflammation in Vulnerable Atherosclerotic Plaques |
Q41093646 | Oleate-induced PTX3 promotes head and neck squamous cell carcinoma metastasis through the up-regulation of vimentin |
Q50143105 | PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer |
Q64105040 | Pentraxin 3 in Cardiovascular Disease |
Q41907221 | Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction - the HUNT2 study. |
Q38991073 | Pentraxins in the activation and regulation of innate immunity |
Q36223775 | Serum Copeptin, Pentraxin 3, Anti-Mullerian Hormone Levels With Echocardiography and Carotid Artery Intima-Media Thickness in Adolescents With Polycystic Ovary Syndrome |
Q34579101 | Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis |
Q55024341 | The association study of high-sensitivity C-reactive protein, pentraxin 3, nitrotyrosine, and insulin dose in patients with insulin-treated type 2 diabetes mellitus. |
Q51129819 | The effect of candesartan on pentraxin-3 plasma levels as marker of endothelial dysfunction in patients with essential arterial hypertension. |
Q47626900 | Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases |
Search more.